All
What is Follicular Lymphoma and Why Are Better Treatments Needed?
CURE® spoke with an expert about follicular lymphoma, a disease that is still considered incurable.
Ryoncil Receives FDA Approval for Children With GVHD
This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease.
FDA Approves Ensacove for ALK-Positive NSCLC
The Food and Drug Administration has approved Ensacove for patients with ALK-positive locally advanced or metastatic non-small cell lung cancer who have not previously received an ALK-inhibitor.
How to Get the Most from Patient Portals During a Cancer Journey
An expert advises a few things to keep in mind when patients with cancer are navigating these platforms.
A Holiday Poem: Who Says Cancer Doesn’t Rhyme?
The holiday season is here, so here’s a festive poem to remind us that cancer should not control us during this time.
Understanding Prostate Cancer Treatment Side Effects Is Key
A study showed that patients with prostate cancer should consider the long-term side effects of treatments before deciding on the appropriate options.
Imbruvica-Venetoclax Shows Promise in Managing CLL
A combination of Imbruvica and venetoclax showed significantly prolonged progression-free survival in patients with untreated CLL, an expert explained.
Surgical Intervention May Improve Survival in Young Patients with Breast Cancer
Younger patients with breast cancer and the BRCA gene showed improved survival after undergoing risk-reducing mastectomy and/or risk-reducing salpingo-oophorectomy.
Why Cancer Caregivers Need to Avoid Burnout
An expert explained the impact that burnout can have on someone caring for a loved one with cancer.
You’re ‘Just Human’: When Cancer Caregivers Need to Ask for Help
Caregivers shouldn’t hesitate to ask for help when it comes to coordinating care for a loved one.
Resources Available for Cancer Caregivers
From counseling services to wellness workshops, there is a wide array of resources potentially available to caregivers, as an expert explained.
How Communication Gaps Can Affect Caregivers and Patients
An expert explained that improved communication will make caregivers of loved ones with cancer feel less isolated.
Keeping Cancer Out of the Closet
I’m very grateful for my SLL medication, but I never thought a side effect of the medication would affect my wardrobe for the rest of my life.
Black Patients With Myeloma Face Taste, Skin Side Effects from Talvey
Black patients may be more affected by certain side effects from Talvey compared with White patients with multiple myeloma, an expert told CURE®.
2025 Medicare Changes ‘Much Simpler’ for Eligible Patients With Cancer
With a significant change happening in the Medicare space in early 2025, patients with cancer eligible for Medicare may see its benefits soon.
First Patient Enrolled Receives Kimmtrak in Phase 3 Uveal Melanoma Trial
The first patient was enrolled in a phase 3 trial for patients with non-metastatic uveal melanoma to either receive Kimmtrak or observation.
Delivering Answers to Pressing Questions About Cancer
At CURE, we remain steadfastly dedicated to providing our readers with answers about cancer research.
My Dog and Thoughts of Gratitude After Cancer
During this holiday season, I wanted to take a moment and reflect on how my dog Payton stayed by my side during acute myeloid leukemia.
Tecartus After Outpatient Lymphodepletion Safe, Effective in B-ALL and MCL
Outpatient lymphodepletion followed by Tecartus was found to be safe and effective in treating B-cell acute lymphoblastic leukemia and mantle cell lymphoma.
Camrelizumab Plus Chemo May Be New Presurgical Option in Breast Cancer Subset
Presurgical camrelizumab plus chemotherapy significantly improved responses versus chemotherapy alone in early or locally advanced TNBC.
An Extraordinary Healer Inside and Out
Oncology nurse Denise always makes it a point to focus on the “big picture” for all of her patients with cancer.
CAN-2409 Elicits Promising Responses in Localized Prostate Cancer
CAN-2409 resulted in disease-free survival improvements for patients with high-risk, localized prostate cancer.
SOXRC Regimen Improves Responses Versus Chemo Alone in Advanced Gastric Cancers
Patients with locally advanced gastric cancers saw complete response rates of 18.3% from camrelizumab and rivoceranib plus chemotherapy.
FDA Approves Unloxcyt for Locally Advanced, Metastatic Skin Cancer Subset
Unloxcyt was approved by the FDA as a new treatment for patients with locally advanced or metastatic cutaneous squamous cell carcinoma.
Tecentriq Regimen Misses End Goal in Triple-Negative Breast Cancer
Tecentriq plus chemotherapy did not improve event-free survival in triple-negative breast cancer but increased rate of complete tumor removal.
Cancer Taught Me to Make the Best of Everything
As a survivor of MDS, I’ve learned to make the best of every day and to be thankful for life. Sometimes this means avoiding others who are less grateful.
‘Golden Bachelor’ Reveals Cancer Diagnosis, Ryne Sandberg’s Cancer Has Returned and More
From Gerry Turner announcing he has cancer to the return of a Chicago Cubs legend’s disease, here’s what’s happening in the cancer space this week.
HER3-DXd With or Without Femara Effective for Some With High-Risk Breast Cancer
Patients with high-risk, HR-positive, HER2-negative breast cancer treated with HER3-DXd with or without Femara (letrozole) experienced fewer side effects than with chemotherapy.
Understanding Genetics May Predict Treatment Response in Triple-Negative Breast Cancer
Several biomarkers may predict improved treatment responses and outcomes in patients with triple-negative breast cancer.
Postoperative Radiation Offers Higher Quality of Life, Fewer Side Effects in Some with Breast Cancer
Radiation therapy resulted in improved quality of life and fewer side effects for older patients with stage 1 luminal-like breast cancer than endocrine therapy.
